論文・技術情報追加のお知らせ

①Does eltrombopag lead to thrombotic events? A pharmacovigilance study of the FDA adverse event reporting system.

エルトロンボパグによる血栓の有害事象のファーマコビジランス研究

対象DB：FAERS

②Immune Checkpoint Inhibitor-related New-onset Thyroid Dysfunction: A Retrospective Analysis Using the US FDA Adverse Event Reporting System.

免疫チェックポイント阻害剤に関連する新規発症の甲状腺機能障害調査

対象DB：FAERS

③Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations.

mRNA COVID-19ワクチン接種後の若年成人における心筋炎および心嚢炎のリスク

対象DB：VAERS

④Association of Current Active Illnesses and Severe Acute Kidney Injury after COVID-19 Vaccines: A Real-World Study.

COVID-19ワクチン接種後の急性腎障害に関する関連性調査研究

対象DB：VAERS

⑤Analysis of drug-induced hand-foot syndrome using a spontaneous reporting system database.

抗がん剤による薬剤性手足症候群の解析

対象DB：JADER

⑥A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases.

選択的セロトニン再取り込み阻害薬誤用、乱用、依存のファーマコビジランス研究

対象DB：FAERS,EudraVigllance